S1801. Practice changing data in high risk clinical stage 3 melanoma showing clear benefit in neoadjuavnt immunotherapy. Congratulations @DrSapnaPatel @SWOG on publishing the results in @NEJM.

Pleased to report our paper demonstrating that CD4s detect MHCII presented antigens on APCs not tumor cells.

The @UCSDCancer team made 3 of the "23 oncology firsts" for 2022! #1 - preclinical model of appendiceal cancer #5 - advanced prostate cancer tx with Pluvicto #23 - employing high-intensity ultrasound as a minimally invasive prostate cancer treatment https://t.co/fYXZzrqONR

Scientists have a theory on covid loss of smell: Damage to nasal cells: great research by UCSD Otolaryngologist Carol Yan!

Happy Holidays from UCSD Moores Cancer Center means a 3D confocal video of poinsettia pollen (green) on a pistil (red) taken by Califano lab member Riyam Al-Msari at consortium partner LJI…enjoy! #UCSD #MooresCancerCenter #LaJollaInstituteforImmunology

The Highly Cited Researchers list identifies exceptional researchers who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. #UCSanDiego ranks 8th in the world for 2022. https://t.co/0lkXNQ0TuW

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect- excited to explore this strategy in #HNSCC ⁦@NatureCancer⁩ ⁦@CalifanoMd⁩ ⁦@DrEzraCohen⁩ ⁦@romleidner⁩ ⁦@SilvioGutkind⁩ ⁦@rsaddawi

Evidence is mounting for changing radiotherapy dogma in the immunotherapy era. https://t.co/GLhunO94mP

Interesting approach to target TAMs. https://t.co/uLNnUuox8B

My new boss surfs. And is a surgeon. And researches head and neck cancer. He’s pretty awesome. Congrats @CalifanoMd on the role- and making the cover of @TheCancerLetter.

Surfer Researcher Surgeon and now @UCSDCancer Moores Cancer Center Director Dr. Joe Califano - @CalifanoMd #DeliveringDiscoveries

IFHNOS Virtual World Tour (Eastern Hemisphere) on 12th November, 2022 | 9:30 am – 1 PM (IST). The program will provide state-of-art knowledge and explore the frontiers of Head & Neck cancer diagnosis, treatment through Keynote lectures and tumor boards. #IFHNOSWORLDTOUR2022

Congratulations Silvio from your lab team, for receiving your diploma for your 2019 induction into the National Academy of Medicine! @theNAMedicine @UCSanDiego @UCSDCancer @UCSDHealthSci @UCSDPharm

The first in-person #DeliveringDiscoveries retreat since 2019 is next week! Program includes keynote addresses, breakthrough research presentations, a poster session, and a Shark Tank-like competition for a Scientific Retreat Pilot Project Award. Register:

👀 congrats UC San Diego!! California leading once again.

Register Today! Delivering Discoveries: Updates in Oncology October 29 – 30, 2021 Hyatt Regency La Jolla at Aventine Register here: https://t.co/0pEZsRgz8A #oncology #cme #cancer #research #conference

One of our grateful patient stories is now airing across the nation. Please find the attached story regarding the impact that her journey has made as we continue to serve those in the field of head & neck oncology. @ivanhoenews @UCSDnews @UCSDHealth https://t.co/KzXC2QHEw2

Enjoyed publishing in the @JNCCN re: A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation. Read more:

We wanted to recognize Co-Director of the Gleiberman Head & Neck Cancer Center, Dr. Loren Mell for his appointment to the National Cancer Institute (NCI). Mell will serve as the Co-Chair of the Head and Neck Cancer Steering Committee @theNCI @UCSDHealth Congrats @drlorenmell

Thank you, Don and Karen Cohn. I am beyond honored. Our entire team is incredibly grateful for your generosity, which will help us advance groundbreaking research, educate future neurosurgeons and continue to provide outstanding clinical care. Thank you.